ANALISIS BIAYA TERAPI PASIEN DIABETES MELITUS RAWAT INAP RSUD Dr. MOEWARDI SURAKARTA PERIODE TAHUN 2010

Main Authors: , RIA ISTAMINING DYAH, S.Far, , Prof. Dr. Djoko Wahyono, SU., Apt.
Format: Thesis NonPeerReviewed
Terbitan: [Yogyakarta] : Universitas Gadjah Mada , 2013
Subjects:
ETD
Online Access: https://repository.ugm.ac.id/126076/
http://etd.ugm.ac.id/index.php?mod=penelitian_detail&sub=PenelitianDetail&act=view&typ=html&buku_id=66266
Daftar Isi:
  • In Indonesia, diabetes melitus is a chronic disease which is suffered and need much cost, therefore the cost analysis become an important thing to be considered. The aim of this research is to know cost component, whole mean cost, and to know whether there is correlation between patient factor and types of medicine trough total cost, between types of fund and treatment class with direct medical cost on diabetes melitus in patient RSUD Dr. Moewardi Surakarta. Research on cost analysis diabetes melitus hospitalizing stay patient in RSUD Dr. Moewardi Surakarta used descriptive non experimental research design, data has been taken restrictively from patients medical record with main diagnose diabetes melitus with comorbid which meets inquiry inclusion during periode of January to December 2010, financial department of RSUD Dr. Moewardi Surakarta to know the cost needed and from the pharmacy installation department to know the details of medical from usage by patient during one treatment period. The samples were taken by using simple random sampling. Chi square test was used to know the relation between patient factor, types of medicine, types of fund, and treatment class to the total cost. The result shows the cost which arrange on diabetes melitus in patient RSUD Dr. Moewardi Surakarta periode of 2010 total cost are medical direct cost such as medical cost, administration cost, IGD cost, laboratory cost, hospitalizing stay cost, action cost, visit cost, consumption medical tools, consumption medical source. The mean of treatment total cost on â��JAMKESMAS+PKMS+tidak mampuâ�� patients are Rp.4,127,180 and on â��ASKES PNS+Umum+Kerjasamaâ�� patients are Rp. 3,828,282. the biggest cost on â��JAMKESMAS+PKMS+tidak mampuâ�� patients are laboratory cost (27.02%), medical cost (25.74%) and action cost (17.20%), while the biggest component on â��ASKES PNS+Umum+Kerjasamaâ�� patients are medical cost (27.54%), laboratory cost (23.02%), and action cost (19.00%). The result of chi square test shows that there is relation between the Length Of Stay (LOS) and treatment cost of diabetes melitus in RSUD Dr.Moewardi Surakarta.